Rollance E. Olson - 08 Dec 2022 Form 4 Insider Report for Fabrinet (FN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Dec 2022, 15:55:04 UTC
Prior SEC filing
10 Dec 2021
Next SEC filing
14 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Andrew Chew, Attorney-in-fact for Rollance E. Olson

Key filing fact

Rollance E. Olson filed Form 4 for Fabrinet (FN) on 12 Dec 2022.

Key facts

  • This page summarizes Rollance E. Olson's Form 4 filing for Fabrinet (FN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Dec 2022, 15:55.

Change

  • Previous filing in this sequence was filed on 10 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FN transaction

Ordinary Shares

Award

Transaction value
$0
Shares
+1,679
Change %
+4.4%
Price
$0.000000
Shares after
39,699
Date
08 Dec 2022
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These are restricted share units awarded to the Reporting Person as partial compensation for serving on the Issuer's Board of Directors. Each restricted share unit represents a contingent right to receive one Ordinary Share of Issuer stock and will vest on January 1, 2024, provided the Reporting Person continues to serve through such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .